Previous Article | Next Article 
Journal of Virology, June 2000, p. 4999-5005, Vol. 74, No. 11
0022-538X/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
Induction of CD4+ T-Cell-Independent
Immunoglobulin Responses by Inactivated Influenza Virus
Zhiyi
Sha and
Richard W.
Compans*
Department of Microbiology and Immunology,
Emory University, Atlanta, Georgia 30322
Received 10 January 2000/Accepted 8 March 2000
 |
ABSTRACT |
Through cognate interaction between antigen-specific B-cell and
CD4+ 
T cells, the CD4+ 
T cells
secrete cytokines that initiate immunoglobulin (Ig) class switching
from IgM to IgG. In this study, we show that formalin-inactivated influenza PR8 virus induces virus-specific IgM and IgG responses in the
absence of CD4+ T cells and that all four subclasses of IgG
are produced. The immunized CD4-deficient mice were also found to be
completely protected against lethal infection with live, pathogenic
influenza virus. The ability of CD4+ T-cell-deficient mice
to generate these IgG responses was not found to be impaired when these
mice were depleted of CD8+ T cells with an anti-CD8
monoclonal antibody. In contrast, 
T-cell-deficient mice
(TCR
/
) were not found to produce significant amounts
of IgG upon immunization with formalin-inactivated PR8 virus. These
results suggest that CD4
CD8
double-negative 
T cells are playing a role in regulating Ig class switching in the absence of CD4+ T cells.
 |
INTRODUCTION |
T-cell-independent (TI) antigens are
antigens that stimulate antibody responses in the absence of major
histocompatibility (MHC) class II-restricted T-cell help. TI antigens
fall into two major categories, TI type 1 (TI-1) and TI type 2 (TI-2).
TI-1 antigens are characterized by being mitogenic and inducing
polyclonal B-cell proliferation. TI-2 antigens, which are represented
by polysaccharides, have the properties of high molecular weight, repeating antigenic epitopes, and inability to stimulate MHC class II-dependent T-cell help (21-23). TI antigens induce only
immunoglobulin M (IgM) responses. In contrast, protein antigens are
thought to induce only T-cell-dependent antibody responses, which
include both IgM and IgG responses (21, 22).
CD4+ T helper cells are believed to be essential for
induction of a high-affinity antibody response and for efficient
isotype switching from IgM to IgG production (25, 26).
Through cognate interaction between antigen-specific B cells and
CD4+ 
T cells, the CD4+ 
T cells
secrete cytokines that initiate the Ig class switching process from IgM
to IgG (9, 26, 32). These T-cell-dependent antibody
responses are accompanied by the formation of germinal centers of B
cells in the lymphoid organs such as the spleen and lymph nodes
(14, 16). Recent studies have shown that Ig class switching
can also be induced in T-cell-deficient mice when infected with live
viruses (17, 33, 34). When 
T-cell-deficient mice
(T-cell receptor
chain knockout [TCR
/
] or
T-cell receptor
chain knockout [TCR
/
]) were
infected with live polyomavirus, a protective virus-specific IgG
response was reported in the absence of helper T cells. However, polyomavirus-like particles and soluble capsid antigens (VP1) were
reported not to induce detectable IgG responses. In studies with
vesicular stomatitis virus (VSV), TCR
/
mice were
found to produce neutralizing IgG antibodies when infected with live
VSV or with a recombinant vaccinia virus expressing the VSV
glycoprotein (17). These results suggest that there may be
alternative mechanisms for antibody class switching and induction of
IgG responses.
Formalin inactivation of VSV was reported to have no effect on the
early IgM response after immunization, but class switching from IgM to
IgG was significantly reduced in BALB/c mice (1, 2, 11). Low
doses (2 × 104 PFU) of inactivated VSV did not induce
any measurable neutralizing IgG responses, while high IgG titers were
produced after immunization with the same dose of live virus. A higher
dose (2 × 106 PFU and 1 × 108 PFU)
of inactivated VSV induced almost normal levels of neutralizing IgG
titers. However, when nude mice or mice depleted of CD4+ T
cells with an anti-CD4 monoclonal antibody (MAb) were immunized with
inactivated virus, no detectable virus-specific IgG was produced (2). It was therefore concluded that CD4+ T
cells are required for the generation of class switching from IgM to
IgG when inactivated virus vaccines are used.
In this study, we have investigated whether formalin-inactivated
influenza A/PR8 virus can induce Ig class switching and generate virus-specific IgG responses in the absence of CD4+ T cells.
 |
MATERIALS AND METHODS |
Animals.
C57BL/6J mice,
C57BL/6-Cd4tm1Mak mice, which had a targeted
disruption in their CD4 gene and therefore lacked functional
CD4+ T cells (28);
C57BL/6J-Tcratm1Mom mice, which had a targeted
disruption in their TCR
gene and lacked functional 
T cells
(19); and C57BL/6J-Tcrbtm1Mom mice,
which had a targeted disruption in their TCR
gene and also lacked
functional 
T cells (19) were obtained from the Jackson Laboratory (Bar Harbor, Maine). Some of the mice were bred in
the Department of Animal Resources at Emory University from purchased
breeding pairs. Two age groups of mice were used in this study; one age
group was 16 to 24 weeks old, and the other age group was 6 weeks old.
Virus, immunization, and sampling.
Influenza virus strain
A/PR/8/34 was grown in the allantoic cavity of embryonated hen's eggs
(9 to 11 days old) and purified from allantoic fluid by sucrose
gradient centrifugation at 100,000 × g. For
inactivation, purified virus was mixed with formalin at a final
concentration of 1:4,000 (vol/vol), incubated at 37°C for 72 h,
and then dialyzed against phosphate-buffered saline (PBS) with three
changes. The virus stock was stored in aliquots at
80°C before use.
Inactivation of the virus was confirmed by both plaque assay on
confluent monolayer MDCK cells and inoculation of the virus into 9- to
11-day-old embryonated hen's eggs. For immunization, mice were
immunized with 10 µg of virus protein intramuscularly (i.m.) or
intraperitoneally (i.p.) per 100 µl of PBS at day 0 and day 15. Blood
samples were collected 15 days after priming and 10 days after
boosting. Anesthetized mice were bled from retroorbital veins to obtain
blood samples. Samples were centrifuged at 14,000 rpm, and sera were
stored at
20°C.
In vitro virus neutralization assay.
A standard plaque
reduction assay was performed to determine the PR8 virus-specific
neutralizing titer of the sera as previously described (31).
From 80 to 120 PFU of influenza A/PR8 virus was mixed with serum at
50-, 200-, 1,000-, and 5,000-fold dilutions and incubated at room
temperature for 1 h. Aliquots of 200 µl were added to confluent
MDCK cell monolayers in six-well plates and incubated at 37°C for
1 h, and the plates were shaken gently every 15 min. After
washing, 1.95% white agar in 1× Dulbecco's modified Eagle's medium
containing 1 µg of trypsin was overlaid on the wells. After
incubation at 37°C for 4 days, plates were stained with neutral red.
The numbers of plaques in each well were counted. The neutralizing
antibody titer was expressed as the highest dilution of serum that was
found to reduce the number of plaques by at least 50%.
Antibody responses.
Influenza virus-specific antibodies were
measured by enzyme-linked immunosorbent assay (ELISA) as previously
described (27). Briefly, the assays were performed in
96-well plates (Dynatech, Alexandria, Va.) coated with purified PR8
virus at a concentration of 2 µg/ml in borate-buffered saline buffer.
Dilutions of serum were incubated overnight on coated and blocked ELISA
plates, and the plates were then incubated with horseradish
peroxidase-labeled goat anti-mouse IgG (Southern Biotechnology
Associates, Birmingham, Ala.). After washing with PBS plus 0.05% Tween
20, the substrate ABTS (2,2'-azino-bis-[3-ethylbenzthiazoline sulfonic
acid]; Sigma, St. Louis, Mo.) in phosphate citrate buffer (3 mg/10 ml)
(pH 4.2) containing 0.03% H2O2 was added.
After 30 min of incubation, the color was measured with an ELISA reader
at 405 nm. Each sample was measured in duplicate. For determination of
the relative levels of PR8-specific IgG subtype responses, a
quantitative assay was performed. Standard curves were obtained by
adding purified mouse IgG1, IgG2a, IgG2b, and IgG3 to plates captured
with a precoated goat anti-mouse Ig antibody, and colors were developed
with ABTS substrate and horseradish peroxidase-conjugated goat
antibodies against each IgG subtype. Concentrations of IgG1, IgG2a,
IgG2b, and IgG3 were determined by comparing the reading for the
experimental samples with the standard curves.
In vivo CD8+ T-cell depletion.
CD8+
T cells were depleted in vivo by i.p. injection of purified rat
anti-mouse IgG CD8 MAb (clone 2.43) (40). Antibodies were
purified with a HiTrap protein G column (Pharmacia Biotech) from the
supernatant of hybridoma 2.43 cultures. A total of 100 µg of antibody
was injected i.p. in mice at days
3,
2,
1, and +1 of
immunization, and the injections were repeated every 5 days thereafter.
The effectiveness of depletion was confirmed by fluorescence-activated cell sorting (FACS) (anti-mouse IgG CD8 MAb clone 53-6.7; Becton Dickinson Co., Mountain View, Calif.) analysis of staining of peripheral blood leukocytes from killed mice, and these samples were
found to be 98 to 99% free of CD8+ T cells.
Flow cytometry analysis.
Single-cell suspension from spleens
of mice were made, and 106 cells were stained with
anti-TCR
, anti-CD8, and anti-CD4 MAbs (H57-FITC, 53-6.7-PerCP, and
GK1.5-PE, respectively) (PharMingen, Beckton-Dickinson) for 30 min at
4°C in 100 µl of FACS buffer (PBS containing 0.3% bovine serum
albumin and 0.1% sodium azide). Cells were washed with FACS buffer and
fixed with 2% paraformaldehyde and then analyzed for single-, double-,
and three-color flow cytometry analysis on a FACScan
(Becton-Dickinson). From 10,000 to 20,000 events were counted for each
sample. Forward and side-scattered characteristics were used to
distinguish the lymphocyte population. CELLQuest software (Becton
Dickinson) was used for the analysis.
Challenge studies.
For procedures requiring a lethal
challenge of influenza virus, a mouse-adapted antigenically identical
strain of A/PR/8/34 (provided by Jiri Mestecky, University of Alabama,
Birmingham) was used for intranasal inoculation. Virus (10 times the
50% lethal dose [10 × LD50, 500 PFU]) was
administered by instillation into the nostrils of anesthetized mice in
a volume of 50 µl. The LD50 in CD4+
T-cell-deficient mice was comparable to the LD50 in normal
C57BL/6 mice. Mice were observed daily for 16 days, and all deaths were recorded.
 |
RESULTS |
Inactivated PR/8/34 influenza virus induces CD4+
T-cell-independent IgG responses.
To investigate the potential of
inactivated PR8 virus to induce IgG responses in the absence of
CD4+ T cells, the magnitude of virus-specific IgG responses
to i.m. immunization with inactivated PR8 virus in normal C57BL/6 mice and CD4+ T-cell-deficient mice in a C57BL/6 background were
evaluated by measuring PR8-specific IgG concentrations by ELISA. Mice
from 16 to 24 weeks old were used in this experiment.
Formalin-inactivated influenza PR8 virus was found to induce
virus-specific IgM and IgG antibodies in normal C57BL/6 mice. Analysis
of the isotype distribution of the virus-specific IgG indicated that
all four IgG subclasses were induced by the inactivated virus, with
IgG1 and IgG2a being predominant (Fig.
1). In the CD4+
T-cell-deficient mice, an IgM response was induced in the absence of
functional T helper cells. Furthermore, we also detected the presence
of virus-specific IgG in the CD4+ T-cell-deficient mice,
indicating that CD4+ T-cell-independent antibody class
switching from IgM to IgG took place after the immunization. All four
IgG subclasses were induced, with IgG1 and IgG2a being the predominant
virus-specific subclasses. The magnitude of the responses was on the
average about fivefold lower than that observed in the normal C57B/6
mice. Interestingly, IgA responses were not detected after immunization
in either CD4+ T-cell knockout mice or normal C57B/6 mice,
indicating the lack of class switching to IgA after i.m. immunization
with inactivated PR8 virus. These data suggest that IgG but not IgA
responses can be induced by inactivated virus independent of
CD4+ T helper cells.

View larger version (31K):
[in this window]
[in a new window]
|
FIG. 1.
Magnitude and isotype profiles of serum antibody
responses to i.m. immunization with inactivated PR8 virus in
CD4+ T-cell-deficient and immunocompetent mice.
CD4+ T-cell-deficient mice or C57BL/6 mice (16 weeks old)
were immunized i.m. with 10 µg of inactivated PR8 virus per mouse.
The mice were boosted with the same dose after 15 days. Con,
unimmunized CD4+ T-cell-deficient mice (n = 5). CD4KO, CD4+ T-cell-deficient mice received inactivated
PR8 virus (n = 5). C57B/6: C57BL/6 immunocompetent mice
received inactivated PR8 virus (n = 5). Prime, samples
were measured 15 days after first immunization. Boost, samples were
measured 10 days after boost. Serum samples were assayed in 1:400 and
1:1,600 dilutions. Error bars in this and subsequent figures represent
standard error.
|
|
To examine whether or not the CD4
+ T-cell-independent IgG
responses in these experiments are specific to the i.m. route, we
immunized CD4
+ T-cell knockout C57BL/6 mice i.p. with
formalin-inactivated PR8
virus. Analysis of the serum antibody levels
indicated that both
IgM and IgG were also induced by this route of
immunization. All
four subclasses of antibodies were detected, with
IgG1 being the
dominant response. The magnitude of these antibody
responses was
similar to those observed after i.m. immunization (Fig.
2). These
data suggest that the
CD4
+ T-cell-independent Ig class switching elicited by
inactivated
virus can be induced by multiple routes and is not specific
to
the i.m. route.

View larger version (27K):
[in this window]
[in a new window]
|
FIG. 2.
Antibody responses and isotype distribution of
virus-specific IgG in mice immunized intraperitoneally.
CD4+ T-cell-deficient mice (n = 5) were
immunized i.p. with formalin-inactivated PR8 virus (10 µg/mouse) on
day 0 and boosted on day 15. Serum samples were collected 15 days after
priming and 10 days after boosting. Con, control, unimmunized
CD4+ T-cell-deficient mice. Prime, after first
immunization. Boost, after boost.
|
|
CD8+ T cells are not required for induction of
CD4+ T-cell-independent IgG responses.
It is generally
believed that Ig isotype switching requires the interaction between B
cells and CD4+ T cells, the latter secreting cytokines that
regulate isotype switching. Recent studies have shown that
CD8+ T cells may also produce cytokines, and like
CD4+ T cells, they can be divided into two subsets, Tc1 and
Tc2 (4, 10, 24, 29, 30). Other studies suggested that
CD8+ T cells may help B cells by the cytokines they produce
(5, 8). To investigate whether CD8+ T cells play
a role in the induction of IgG responses in CD4+
T-cell-deficient C57BL/6 mice, we depleted the CD8+ T cells
in these mice by injection of 2.43 antibody. CD8+ T cells
were found to be depleted by approximately 99% in peripheral blood
when analyzed by FACS. When CD4+ T-cell-deficient mice were
immunized i.m. with inactivated PR8 virus, depletion of
CD8+ T cells did not abrogate the observed IgG responses
(Fig. 3). The magnitude and subclass
profile of the IgG responses were found to be similar to those observed
in the CD4+ T-cell knockout mice without CD8+
T-cell depletion. These results provide evidence that CD8+
T cells are not required for the inactivated virus-induced
CD4+ T-cell-independent IgG responses.

View larger version (27K):
[in this window]
[in a new window]
|
FIG. 3.
Antibody responses and IgG isotype profile in
CD8-depleted CD4+ T-cell-deficient C57BL/6 mice after
immunization with inactivated PR8 virus. CD4+
T-cell-deficient mice (n = 5) were depleted of CD8 T
cells by i.p. injection of MAb. 2.43. These mice were then i.m.
immunized with formalin-inactivated PR8 virus (10 µg/mouse) at day 0 and boosted at day 15 with the same dose. Pre, serum samples before
immunization. Prime, serum samples taken at day 15 after first
immunization. Boost, serum samples taken at day 10 after boost.
|
|
Immunization with inactivated PR8 virus in CD4+
T-cell-deficient mice induces neutralizing activity.
To explore
whether immunization with formalin-inactivated PR8 virus in
CD4+ T-cell-deficient mice induces virus-neutralizing
activity in vitro, approximately 100 PFU of PR8 virus were incubated
with serum at different dilutions, and a standard plaque reduction assay was performed on MDCK cells. The neutralizing titer of the sera
from the CD4+ T-cell-deficient mice after the initial
immunization was 1:200, and the titer was higher than 1:1,000 after
boosting (Fig. 4). This result shows that
the immune responses induced in the absence of CD4+ T cells
have virus-neutralizing activity in vitro.

View larger version (13K):
[in this window]
[in a new window]
|
FIG. 4.
Serum virus-neutralizing antibody titers in
CD4+ T-cell-deficient C57BL/6 mice i.m. immunized with
formalin-inactivated PR8 virus. CD4+ T-cell-deficient mice
were immunized i.m. with formalin-inactivated PR8 virus (10 µg/mouse)
at day 0 and boosted at day 15 with the same dose. Different dilutions
of serum samples from immunized mice were mixed with approximately 100 PFU of PR8 virus and incubated for 1 h at room temperature. The
mixtures were then used to infect a monolayer of MDCK cells, and a
standard plaque reduction assay was performed. The
neutralizing-antibody titer of the serum is considered the highest
dilution that was found to reduce the number of plaques by 50% or
more. , control, serum from unimmunized CD4+
T-cell-deficient mice; , serum from CD4+
T-cell-deficient C57BL/6 mice 15 days after priming; , serum from
CD4+ T-cell-deficient C57BL/6 mice 10 days after
boosting.
|
|
CD4+ T-cell-deficient mice are protected from lethal
challenge with live virus after immunization with inactivated
virus.
To investigate whether the observed immune responses can
protect against lethal challenge, the immunized CD4+
T-cell-deficient mice were challenged with 10× the LD50
intranasally under anesthesia. One hundred percent of CD4+
T-cell-deficient mice immunized with inactivated PR8 virus were found
to be protected from lethal infection. In addition, all the
CD8+ T-cell-depleted mice were also protected. In contrast,
unimmunized CD4+ T-cell knockout mice all died on days 6 to
8 after the challenge (Fig. 5). This
result indicates that inactivated virus could induce fully protective
immune responses without the participation of CD4+ T helper
cells.

View larger version (12K):
[in this window]
[in a new window]
|
FIG. 5.
Protection of immunized CD4+
T-cell-deficient mice against lethal PR8 virus challenge.
CD4+ T-cell-deficient C57BL/6 mice i.m. immunized with
inactivated PR8 virus were challenged intranasally with 10 times the
LD50 of live PR8 virus under anesthesia 4 weeks after
boost. (a) Control, unimmunized CD4+ T-cell-deficient
C57BL/6 mice. (b) CD4+ T-cell-deficient C57BL/6 mice
immunized with inactivated PR8 virus. (c) CD8 T-cell-depleted
CD4+ T-cell-deficient C57BL/6 mice immunized with
inactivated PR8 virus.
|
|
TCR
+ T-cell-deficient mice are unable to produce
IgG responses after immunization with inactivated PR8 virus.
To
investigate whether mice deficient in total TCR
+ T
cells were capable of mounting antiviral IgG responses after
immunization with inactivated influenza virus, we examined the
virus-specific antibody responses of TCR
/
mice after
immunization with formalin-inactivated PR8 virus. We observed that the
TCR
/
mice produced IgM responses after immunization
with inactivated virus; the levels of IgM observed after priming and
boosting were similar. However, the TCR
/
mice did
not develop significant virus-specific IgG responses after immunization
with the inactivated PR8 virus. No IgG1, IgG2a, or IgG2b responses
could be detected, and only very low levels of IgG3 were produced (Fig.
6). These results indicate that although CD4+ and CD8+ T cells are not required, a
population of 
+ T cells is indispensable for IgG
production after immunization with inactivated PR8 virus.

View larger version (18K):
[in this window]
[in a new window]
|
FIG. 6.
Isotype profile of PR8 virus-specific antibody responses
of T-cell-deficient mice. TCR / mice were i.m.
immunized with formalin-inactivated PR8 virus (10 µg/mouse) at day 0 and boosted at day 15. Serum samples were obtained 15 days after
priming and 10 days after boosting. Con, control, unimmunized
TCR / mice; PR8, TCR / mice
immunized with formalin-inactivated PR8 virus. Prime and Boost are
defined in the legend to Fig. 1.
|
|
Magnitude of IgG responses to inactivated PR8 virus is age
dependent.
During these experiments, we observed that younger
CD4+ T-cell knockout mice produced lower levels of IgG
responses than older mice. In this experiment, 6-week-old
CD4+ T-cell-deficient C57BL/6 mice were immunized i.m. with
formalin-inactivated PR8 virus. A significant amount of IgM and all
four subclasses of IgG were produced, but their levels on the average
were five- to six-fold lower than those of the 16-week-old mice. IgG1
was predominant among the four subclasses of IgG, similar to the
pattern observed in old mice (Fig. 7).
These data indicate that younger CD4+ T-cell knockout mice
produce lower levels of IgG responses than older mice.

View larger version (24K):
[in this window]
[in a new window]
|
FIG. 7.
Antibody responses and isotype distribution of
virus-specific IgG in 6-week-old mice i.m. immunized with inactivated
PR8 virus. Six-week-old mice (n = 4) were immunized
intramuscularly with formalin-inactivated PR8 virus (10 µg/mouse) on
day 0 and boosted on day 15. Serum samples were collected 10 days after
boosting. Con, control, unimmunized CD4+ T-cell-deficient
mice. Boost, serum samples after boost.
|
|
CD4+ T-cell-deficient mice contain higher levels of
CD4
CD8
DN T cells in the spleen than
normal C57BL/6 mice.
To investigate whether CD4+
T-cell-deficient mice have the same double-negative (DN) T-cell
population as normal C57BL/6 mice, we analyzed different T-cell
populations in these mice by flow cytometry after staining the T cells
with anti-TCR
, anti-CD8, and anti-CD4 MAbs. In normal 6-month-old
C57BL/6 mice, DN T cells account for about 2% of the T-cell
population. In contrast, DN T cells were found to constitute about 30%
of the total T-cell population in 6-month-old CD4+
T-cell-deficient mice and about 15% in younger (6 week old)
CD4+ T-cell-deficient mice (Fig.
8). These results demonstrate that higher
levels of DN T cells are produced in CD4+ T-cell-deficient
mice than in normal mice.

View larger version (17K):
[in this window]
[in a new window]
|
FIG. 8.
Flow cytometry analysis of  T cells in
CD4+ T-cell-deficient mice. Spleen cells from C57BL/6 mice
or CD4+ T-cell-deficient mice were stained with
anti-TCR , anti-CD8, and anti-CD4 MAbs (H57-FITC, 53-6.7-PerCP, and
GK1.5-PE, respectively, from PharMingen and Beckton-Dickinson). Plots
show TCR -gated cells. Samples were from (a) a 16-week-old C57BL/6
mouse, (b) a 6-month-old CD4+ T-cell-deficient mouse, and
(c) a 6-week-old CD4+ T-cell-deficient mouse.
|
|
 |
DISCUSSION |
We show in this study that formalin-inactivated influenza PR8
virus induces IgM and IgG responses in the absence of CD4+
T cells. All four subclasses of IgG were produced, with IgG1 and IgG2a
being predominant. The sera from the immunized mice were also found to
have neutralizing activity against influenza virus in vitro. The
immunized CD4+ T-cell-deficient mice were also shown to be
protected from intranasal challenge with lethal doses of live PR8
virus. To our knowledge, this is the first report that an inactivated
virus can induce B-cell differentiation and isotype switching from IgM
to IgG that is completely independent of CD4+ T helper cells.
The ability of CD4+ T-cell-deficient mice to generate IgG
responses after immunization with inactivated PR8 virus was also not
found to be impaired when these mice were depleted of CD8+
T cells with an anti-CD8 MAb. In contrast, 
+
T-cell-deficient mice (TCR
/
and
TCR
/
) were not observed to produce significant
amounts of IgG upon immunization with formalin-inactivated PR8 virus.
These results suggested that CD4
CD8
DN T
cells are playing a role in regulating Ig class switching in the
absence of CD4+ T cells. To our knowledge, this is also the
first evidence that CD4
CD8
DN 
T
cells play a role in Ig class switching and generation of IgG antibody
in the immune response against viral pathogens.
The magnitude of virus-specific IgM responses in 
+
T-cell-deficient mice is comparable to that in CD4+
T-cell-deficient mice after immunization with inactivated PR8 virus.
However, CD4+ T-cell-deficient mice were protected from the
lethal dose challenge with live PR8 virus, but 
+
T-cell-deficient mice were not protected (data not shown). These observations suggest that the protective effect is mainly a result of
IgG responses and not IgM responses.
The presence of CD4
CD8
DN T helper cells
in the CD4+ T-cell-deficient mice is consistent with recent
results from CD4+-deficient mice infected with
Leishmania major (6, 15). T-cell-deficient nude
mice and severe combined immunodeficient (SCID) mice cannot control
L. major infection and the fatal dissemination of the parasite (12, 18). In contrast, CD4
/
mice
were reported to be resistant to the infection, and resolution of the
infection occurs within 6 weeks. The DN TCR
+ T cells
purified from infected CD4
/
mice were found to have
gamma interferon (IFN-
) transcripts comparable in amount to that in
the CD4+ population purified from infected
CD4+/
animals (26). The IFN-
production was
also found to be comparable in these purified populations. MAb to
IFN-
abrogated the ability of CD4
/
mice to recover
from L. major infection. Although CD4
CD8
DN 
T cells are present in normal C57BL/6 mice,
they account for only 2% of the T cells in the spleen. It is unlikely
that this population plays a major role in Ig class switching in the presence of CD4+ T cells. In contrast, we observed that DN
T cells constitute of almost 30% of the T-cell population in
6-month-old CD4+ T-cell-deficient mice. We suggest that
these DN T cells may compensate for the functions of the
CD4+ T cells which are absent in those mice. The
quantitative difference in DN T cell levels between older and younger
mice may reflect the different amounts of antibodies produced in these
CD4+ T-cell-deficient mice.
Formalin-inactivated VSV was not observed to induce Ig class switching
and IgG production in normal mice depleted of CD4+ T cells,
which differs from the results obtained with influenza virus in our
study. There are several possible explanations for this difference.
First, influenza virus may have unique properties as an antigen.
Influenza virions bind efficiently to any cell surfaces that contain
sialic acid because of the receptor-binding activity of the
hemagglutinin glycoprotein (37), and such binding may
promote cell-to-cell contacts that could be involved in antibody induction. In contrast to VSV, influenza virions lack sialic acid on
their surface (13) and can therefore bind to
asialoglycoprotein receptors. There may also be differences between the
effects of acute depletion of CD4+ T cells in normal mice
versus the development of the immune system in congenital
CD4+ T-cell-deficient mice, in which a compensatory
mechanism may develop. This is supported by our result that a large
number of DN T cells exist in the spleens of the CD4+
T-cell-deficient mice. Other studies with TCR mutant mice also support
this hypothesis (20, 36).
The available data suggest that different antigens may use different
mechanisms and cells to induce Ig class switching in mice when
conventional 
T cells are absent (7, 17, 33, 38, 39).
In the case of VSV, the neutralizing IgG responses were crucially
dependent on IFN-
and were predominantly of the IgG2a subtype. This
class-switching effect was reported to be abolished when 
T cells
are absent, indicating that 
T cells are playing a role in Ig
class switching when 
T cells are absent (17). Studies
with a mouse model of human systemic lupus erythematosus had also
revealed that 
T cells can induce Ig class switching (38). This type of B-T interaction sustains the production
of germinal centers that are usually the result of 
T-cell and B-cell collaboration. In contrast, polyomavirus was reported to induce
IgG responses in both TCR
/
mice and
TCR
x
/
mice, with similar virus-specific IgG
titers, suggesting that TCR
+ T cells do not seem to
play a role in helping the Ig class-switching process for this virus
antigen (33-35).
Our results indicate that the CD4
CD8
DN T
cells will trigger B-cell proliferation, differentiation, and isotype
switching from IgM to IgG even in the complete absence of
CD4+ T helper cells. These finding may have important
practical implications. Usually, live attenuated virus vaccines are not
administered to immunocompromised patients because of their potential
to cause life-threatening infections. Inactivated virus vaccines would be the choice for use in these situations. In these patients, especially AIDS patients whose CD4 counts are extremely low, the "help" from CD4
CD8
DN T cells may
allow the generation of long-lasting protective IgG immune responses
against viral pathogens by vaccination with inactivated viral vaccines
even with an impaired CD4+ T helper cell function. This
notion is supported by the finding that antibodies directed against the
gp120 Env protein persisted even at advanced stages of this disease,
when the CD4+ T-cell count is very low
(3).
 |
FOOTNOTES |
*
Corresponding author. Mailing address: Department of
Microbiology and Immunology, Emory University, Atlanta, GA 30322. Phone: (404) 727-5947. Fax: (404) 727-8250. E-mail:
compans{at}microbio.emory.edu.
 |
REFERENCES |
| 1.
|
Bachmann, M. F.,
H. Hengartner, and R. M. Zinkernagel.
1995.
T helper cell-independent neutralizing B cell response against vesicular stomatitis virus: role of antigen patterns in B cell induction?
Eur. J. Immunol.
25:3445-3451[Medline].
|
| 2.
|
Bachmann, M. F.,
T. M. Kundig,
C. P. Kalberer,
H. Hengartner, and R. M. Zinkernagel.
1993.
Formalin inactivation of vesicular stomatitis virus impairs T-cell- but not T-help-independent B-cell responses.
J. Virol.
67:3917-3922[Abstract/Free Full Text].
|
| 3.
|
Binley, J. M.,
P. J. Klasse,
Y. Cao,
I. Jones,
M. Markowitz,
D. D. Ho, and J. P. Moore.
1997.
Differential regulation of the antibody responses to Gag and Env proteins of human immunodeficiency virus type 1.
J. Virol.
71:2799-2809[Abstract].
|
| 4.
|
Croft, M.,
L. Carter,
S. L. Swain, and R. W. Dutton.
1994.
Generation of polarized antigen-specific CD8 effector populations: reciprocal action of interleukin (IL)-4 and IL-12 in promoting type 2 versus type 1 cytokine profiles.
J. Exp. Med.
180:1715-1728[Abstract/Free Full Text].
|
| 5.
|
Cronin, D. C., 2nd,
R. Stack, and F. W. Fitch.
1995.
IL-4-producing CD8+ T cell clones can provide B cell help.
J. Immunol.
154:3118-3127[Abstract].
|
| 6.
|
Davis, C. B.,
N. Killeen,
M. E. Crooks,
D. Raulet, and D. R. Littman.
1993.
Evidence for a stochastic mechanism in the differentiation of mature subsets of T lymphocytes.
Cell
73:237-247[CrossRef][Medline].
|
| 7.
|
Dianda, L.,
A. Gulbranson-Judge,
W. Pao,
A. C. Hayday,
I. C. MacLennan, and M. J. Owen.
1996.
Germinal center formation in mice lacking alpha beta T cells.
Eur. J. Immunol.
26:1603-1607[Medline].
|
| 8.
|
Erard, F.,
M. T. Wild,
J. A. Garcia-Sanz, and G. Le Gros.
1993.
Switch of CD8 T cells to noncytolytic CD8-CD4- cells that make TH2 cytokines and help B cells.
Science
260:1802-1805[Abstract/Free Full Text].
|
| 9.
|
Finkelman, F. D.,
J. Holmes,
I. M. Katona,
J. F. Urban, Jr.,
M. P. Beckmann,
L. S. Park,
K. A. Schooley,
R. L. Coffman,
T. R. Mosmann, and W. E. Paul.
1990.
Lymphokine control of in vivo immunoglobulin isotype selection.
Annu. Rev. Immunol.
8:303-333[CrossRef][Medline].
|
| 10.
|
Fong, T. A., and T. R. Mosmann.
1990.
Alloreactive murine CD8+ T cell clones secrete the Th1 pattern of cytokines.
J. Immunol.
144:1744-1752[Abstract].
|
| 11.
|
Freer, G.,
C. Burkhart,
I. Ciernik,
M. F. Bachmann,
H. Hengartner, and R. M. Zinkernagel.
1994.
Vesicular stomatitis virus Indiana glycoprotein as a T-cell-dependent and -independent antigen.
J. Virol.
68:3650-3655[Abstract/Free Full Text].
|
| 12.
|
Holaday, B. J.,
M. D. Sadick,
Z. E. Wang,
S. L. Reiner,
F. P. Heinzel,
T. G. Parslow, and R. M. Locksley.
1991.
Reconstitution of Leishmania immunity in severe combined immunodeficient mice using Th1- and Th2-like cell lines.
J. Immunol.
147:1653-1658[Abstract].
|
| 13.
|
Klenk, H. D.,
W. Keil,
H. Niemann,
R. Geyer, and R. T. Schwarz.
1983.
The characterization of influenza A viruses by carbohydrate analysis.
Curr. Top. Microbiol. Immunol.
104:247-257[Medline].
|
| 14.
|
Liu, Y. J.,
G. D. Johnson,
J. Gordon, and I. C. MacLennan.
1992.
Germinal centres in T-cell-dependent antibody responses.
Immunol. Today
13:17-21[CrossRef][Medline].
|
| 15.
|
Locksley, R. M.,
S. L. Reiner,
F. Hatam,
D. R. Littman, and N. Killeen.
1993.
Helper T cells without CD4: control of leishmaniasis in CD4-deficient mice.
Science
261:1448-1451[Abstract/Free Full Text].
|
| 16.
|
MacLennan, I. C.
1994.
Germinal centers.
Annu. Rev. Immunol.
12:117-139[CrossRef][Medline].
|
| 17.
|
Maloy, K. J.,
B. Odermatt,
H. Hengartner, and R. M. Zinkernagel.
1998.
Interferon gamma-producing gammadelta T cell-dependent antibody isotype switching in the absence of germinal center formation during virus infection.
Proc. Natl. Acad. Sci. USA
95:1160-1165[Abstract/Free Full Text].
|
| 18.
|
Mitchell, G. F.
1983.
Murine cutaneous leishmaniasis: resistance in reconstituted nude mice and several F1 hybrids infected with Leishmania tropica major.
J. Immunogenet.
10:395-412[Medline].
|
| 19.
|
Mombaerts, P.,
A. R. Clarke,
M. A. Rudnicki,
J. Iacomini,
S. Itohara,
J. J. Lafaille,
L. Wang,
Y. Ichikawa,
R. Jaenisch,
M. L. Hooper, et al.
1992.
Mutations in T-cell antigen receptor genes alpha and beta block thymocyte development at different stages.
Nature
360:225-231[CrossRef][Medline]. (Erratum, 360:491.)
|
| 20.
|
Mombaerts, P.,
E. Mizoguchi,
H. G. Ljunggren,
J. Iacomini,
H. Ishikawa,
L. Wang,
M. J. Grusby,
L. H. Glimcher,
H. J. Winn,
A. K. Bhan, et al.
1994.
Peripheral lymphoid development and function in TCR mutant mice.
Int. Immunol.
6:1061-1070[Abstract/Free Full Text].
|
| 21.
|
Mond, J. J.,
A. Lees, and C. M. Snapper.
1995.
T cell-independent antigens type 2.
Annu. Rev. Immunol.
13:655-692[CrossRef][Medline].
|
| 22.
|
Mond, J. J.,
Q. Vos,
A. Lees, and C. M. Snapper.
1995.
T cell independent antigens.
Curr. Opin. Immunol.
7:349-354[CrossRef][Medline].
|
| 23.
|
Mosier, D. E.,
J. J. Mond, and E. A. Goldings.
1977.
The ontogeny of thymic independent antibody responses in vitro in normal mice and mice with an X-linked B cell defect.
J. Immunol.
119:1874-1878[Abstract/Free Full Text].
|
| 24.
|
Mosmann, T. R.,
L. Li, and S. Sad.
1997.
Functions of CD8 T-cell subsets secreting different cytokine patterns.
Semin. Immunol.
9:87-92[CrossRef][Medline].
|
| 25.
|
Oxenius, A.,
R. M. Zinkernagel, and H. Hengartner.
1998.
CD4+ T-cell induction and effector functions: a comparison of immunity against soluble antigens and viral infections.
Adv. Immunol.
70:313-367[Medline].
|
| 26.
|
Parker, D. C.
1993.
T cell-dependent B cell activation.
Annu. Rev. Immunol.
11:331-360[Medline].
|
| 27.
|
Pertmer, T. M.,
T. R. Roberts, and J. R. Haynes.
1996.
Influenza virus nucleoprotein-specific immunoglobulin G subclass and cytokine responses elicited by DNA vaccination are dependent on the route of vector DNA delivery.
J. Virol.
70:6119-6125[Abstract].
|
| 28.
|
Rahemtulla, A.,
W. P. Fung-Leung,
M. W. Schilham,
T. M. Kundig,
S. R. Sambhara,
A. Narendran,
A. Arabian,
A. Wakeham,
C. J. Paige,
R. M. Zinkernagel, et al.
1991.
Normal development and function of CD8+ cells but markedly decreased helper cell activity in mice lacking CD4.
Nature
353:180-184[CrossRef][Medline].
|
| 29.
|
Sad, S.,
R. Marcotte, and T. R. Mosmann.
1995.
Cytokine-induced differentiation of precursor mouse CD8+ T cells into cytotoxic CD8+ T cells secreting Th1 or Th2 cytokines.
Immunity
2:271-279[CrossRef][Medline].
|
| 30.
|
Salgame, P.,
J. S. Abrams,
C. Clayberger,
H. Goldstein,
J. Convit,
R. L. Modlin, and B. R. Bloom.
1991.
Differing lymphokine profiles of functional subsets of human CD4 and CD8 T cell clones.
Science
254:279-282[Abstract/Free Full Text].
|
| 31.
|
Sha, Z.,
M. J. Vincent, and R. W. Compans.
1999.
Enhancement of mucosal immune responses to the influenza virus HA protein by alternative approaches to DNA immunization.
Immunobiology
200:21-30[Medline].
|
| 32.
|
Snapper, C. M., and J. J. Mond.
1993.
Towards a comprehensive view of immunoglobulin class switching.
Immunol. Today
14:15-17[CrossRef][Medline].
|
| 33.
|
Szomolanyi-Tsuda, E.,
Q. P. Le,
R. L. Garcea, and R. M. Welsh.
1998.
T-cell-independent immunoglobulin G responses in vivo are elicited by live-virus infection but not by immunization with viral proteins or virus-like particles.
J. Virol.
72:6665-6670[Abstract/Free Full Text].
|
| 34.
|
Szomolanyi-Tsuda, E., and R. M. Welsh.
1996.
T cell-independent antibody-mediated clearance of polyoma virus in T cell-deficient mice.
J. Exp. Med.
183:403-411[Abstract/Free Full Text].
|
| 35.
|
Szomolanyi-Tsuda, E., and R. M. Welsh.
1998.
T-cell-independent antiviral antibody responses.
Curr. Opin. Immunol.
10:431-435[CrossRef][Medline].
|
| 36.
|
Viney, J. L.,
L. Dianda,
S. J. Roberts,
L. Wen,
C. A. Mallick,
A. C. Hayday, and M. J. Owen.
1994.
Lymphocyte proliferation in mice congenitally deficient in T-cell receptor alpha beta + cells.
Proc. Natl. Acad. Sci. USA
91:11948-11952[Abstract/Free Full Text].
|
| 37.
|
Weis, W.,
J. H. Brown,
S. Cusack,
J. C. Paulson,
J. J. Skehel, and D. C. Wiley.
1988.
Structure of the influenza virus haemagglutinin complexed with its receptor, sialic acid.
Nature
333:426-431[CrossRef][Medline].
|
| 38.
|
Wen, L.,
W. Pao,
F. S. Wong,
Q. Peng,
J. Craft,
B. Zheng,
G. Kelsoe,
L. Dianda,
M. J. Owen, and A. C. Hayday.
1996.
Germinal center formation, immunoglobulin class switching, and autoantibody production driven by "non alpha/beta" T cells.
J. Exp. Med.
183:2271-2282[Abstract/Free Full Text].
|
| 39.
|
Wen, L.,
S. J. Roberts,
J. L. Viney,
F. S. Wong,
C. Mallick,
R. C. Findly,
Q. Peng,
J. E. Craft,
M. J. Owen, and A. C. Hayday.
1994.
Immunoglobulin synthesis and generalized autoimmunity in mice congenitally deficient in alpha beta(+) T cells.
Nature
369:654-658[CrossRef][Medline].
|
| 40.
|
Wilde, D. B.,
P. Marrack,
J. Kappler,
D. P. Dialynas, and F. W. Fitch.
1983.
Evidence implicating L3T4 in class II MHC antigen reactivity; monoclonal antibody GK1.5 (anti-L3T4a) blocks class II MHC antigen-specific proliferation, release of lymphokines, and binding by cloned murine helper T lymphocyte lines.
J. Immunol.
131:2178-2183[Abstract].
|
Journal of Virology, June 2000, p. 4999-5005, Vol. 74, No. 11
0022-538X/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Zhu, Q., Zarnitsyn, V. G., Ye, L., Wen, Z., Gao, Y., Pan, L., Skountzou, I., Gill, H. S., Prausnitz, M. R., Yang, C., Compans, R. W.
(2009). Immunization by vaccine-coated microneedle arrays protects against lethal influenza virus challenge. Proc. Natl. Acad. Sci. USA
106: 7968-7973
[Abstract]
[Full Text]
-
Quan, F. S., Yoo, D.-G., Song, J.-M., Clements, J. D., Compans, R. W., Kang, S.-M.
(2009). Kinetics of Immune Responses to Influenza Virus-Like Particles and Dose-Dependence of Protection with a Single Vaccination. J. Virol.
83: 4489-4497
[Abstract]
[Full Text]
-
Xu, W., Santini, P. A., Matthews, A. J., Chiu, A., Plebani, A., He, B., Chen, K., Cerutti, A.
(2008). Viral Double-Stranded RNA Triggers Ig Class Switching by Activating Upper Respiratory Mucosa B Cells through an Innate TLR3 Pathway Involving BAFF. J. Immunol.
181: 276-287
[Abstract]
[Full Text]
-
Quan, F.-S., Compans, R. W., Nguyen, H. H., Kang, S.-M.
(2008). Induction of Heterosubtypic Immunity to Influenza Virus by Intranasal Immunization. J. Virol.
82: 1350-1359
[Abstract]
[Full Text]
-
Yang, R., Murillo, F. M., Delannoy, M. J., Blosser, R. L., Yutzy, W. H. IV, Uematsu, S., Takeda, K., Akira, S., Viscidi, R. P., Roden, R. B. S.
(2005). B Lymphocyte Activation by Human Papillomavirus-Like Particles Directly Induces Ig Class Switch Recombination via TLR4-MyD88. J. Immunol.
174: 7912-7919
[Abstract]
[Full Text]
-
Zhou, X., Robertson, A.-K. L., Rudling, M., Parini, P., Hansson, G. K.
(2005). Lesion Development and Response to Immunization Reveal a Complex Role for CD4 in Atherosclerosis. Circ. Res.
96: 427-434
[Abstract]
[Full Text]
-
Kang, S.-M., Guo, L., Yao, Q., Skountzou, I., Compans, R. W.
(2004). Intranasal Immunization with Inactivated Influenza Virus Enhances Immune Responses to Coadministered Simian-Human Immunodeficiency Virus-Like Particle Antigens. J. Virol.
78: 9624-9632
[Abstract]
[Full Text]
-
Yao, Q., Zhang, R., Guo, L., Li, M., Chen, C.
(2004). Th Cell-Independent Immune Responses to Chimeric Hemagglutinin/Simian Human Immunodeficiency Virus-Like Particles Vaccine. J. Immunol.
173: 1951-1958
[Abstract]
[Full Text]
-
Moore, M. L., Brown, C. C., Spindler, K. R.
(2003). T Cells Cause Acute Immunopathology and Are Required for Long-Term Survival in Mouse Adenovirus Type 1-Induced Encephalomyelitis. J. Virol.
77: 10060-10070
[Abstract]
[Full Text]
-
Fischer, T., Planz, O., Stitz, L., Rziha, H.-J.
(2003). Novel Recombinant Parapoxvirus Vectors Induce Protective Humoral and Cellular Immunity against Lethal Herpesvirus Challenge Infection in Mice. J. Virol.
77: 9312-9323
[Abstract]
[Full Text]
-
Ganta, R. R., Wilkerson, M. J., Cheng, C., Rokey, A. M., Chapes, S. K.
(2002). Persistent Ehrlichia chaffeensis Infection Occurs in the Absence of Functional Major Histocompatibility Complex Class II Genes. Infect. Immun.
70: 380-388
[Abstract]
[Full Text]